Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

PD -1/PD-L1 monoclonal antibody

Solid Cancer

PhasePhase 2
StatusRECRUITING
SponsorUnknown
Enrolment65
Primary completion2027-09-01
Primary endpointObjective Response Rate #ORR#
Registry IDNCT07267234

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:32:43.535Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07267234

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
PD -1/PD-L1 monoclonal antibody — trial | AEaH